Authors: BERENS RL KRUG EC NASH PB CURIEL TJ

Citation: Rl. Berens et al., SELECTION AND CHARACTERIZATION OF TOXOPLASMA-GONDII MUTANTS RESISTANTTO ARTEMISININ, The Journal of infectious diseases, 177(4), 1998, pp. 1128-1131

Authors: PURNER MB BERENS RL NASH PB VANLINDEN A ROSS E KRUSE C KRUG EC CURIEL TJ

Citation: Mb. Purner et al., CD4-MEDIATED AND CD8-MEDIATED CYTOTOXIC AND PROLIFERATIVE IMMUNE-RESPONSES TO TOXOPLASMA-GONDII IN SEROPOSITIVE HUMANS, Infection and immunity, 64(10), 1996, pp. 4330-4338

Authors: PURNER MB KRUG EC NASH A COOK DR BERENS RL CURIEL TJ

Citation: Mb. Purner et al., CROSS-REACTIVITY OF HUMAN TOXOPLASMA-SPECIFIC T-CELLS - IMPLICATIONS FOR DEVELOPMENT OF A POTENTIAL IMMUNOTHERAPEUTIC OR VACCINE, The Journal of infectious diseases, 171(4), 1995, pp. 984-991

Authors: PURNER MB BERENS RL KRUG EC CURIEL TJ

Citation: Mb. Purner et al., EPSTEIN-BARR VIRUS-TRANSFORMED B-CELLS, A POTENTIALLY CONVENIENT SOURCE OF AUTOLOGOUS ANTIGEN-PRESENTING CELLS FOR THE PROPAGATION OF CERTAIN HUMAN CYTOTOXIC T-LYMPHOCYTES, Clinical and diagnostic laboratory immunology, 1(6), 1994, pp. 696-700

Authors: CURIEL TJ KRUG EC PURNER MB POIGNARD P BERENS RL

Citation: Tj. Curiel et al., CLONED HUMAN CD4-LYMPHOCYTES SPECIFIC FOR TOXOPLASMA-GONDII LYSE TACHYZOITE-INFECTED TARGET-CELLS( CYTOTOXIC T), The Journal of immunology, 151(4), 1993, pp. 2024-2031